Development of potential anti-sarcopenia agents targeting the integrated stress response
Description: Sarcopenia is associated with increases the risk of physical limitation and lifestyle-related diseases. In current study, we aim to develop a new therapeutic strategy for the treatment of sarcopenia by targeting the integrated stress response (ISR). We performed a comprehensive gene expression analysis of skeletal muscle specific ISR transgenic mice and identified the ISR downstream target gene as a mediator of skeletal muscle atrophy. Skeletal muscle specific ISR defective mice were resistant to atrophy. Furthermore, we established the high-throughput assay to monitor the ISR activation, which allows us to identify the compounds modulating the ISR.
Amount: ¥17,810,000
Funding type: research
Funder scheme: Grant-in-Aid for Scientific Research (B)
Start date: 2016-04-01
End date: 2019-03-31
Investigator: Seiichi OYADOMARI (lead)
Institutions: Tokushima University, The University of Tokushima
Subfield: Molecular Biology
Domain: Life Sciences
Funded outputs count: 14
Funder award ID: 16H05222
OpenAlex ID: G2017809779
